Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dlx1
|
ENSMUSG00000041911.3 | distal-less homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_71531994_71533218 | Dlx1 | 1826 | 0.251523 | -0.22 | 9.2e-02 | Click! |
chr2_71528827_71530354 | Dlx1 | 263 | 0.855576 | -0.15 | 2.6e-01 | Click! |
chr2_71530691_71531882 | Dlx1 | 506 | 0.704437 | -0.15 | 2.7e-01 | Click! |
chr2_71528480_71528631 | Dlx1 | 128 | 0.868591 | -0.08 | 5.6e-01 | Click! |
chr2_71530423_71530653 | Dlx1 | 242 | 0.883149 | -0.06 | 6.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_77341896_77342983 | 5.66 |
Mlip |
muscular LMNA-interacting protein |
1812 |
0.31 |
chr13_73262153_73264451 | 5.14 |
Irx4 |
Iroquois homeobox 4 |
2805 |
0.22 |
chr9_79976568_79977294 | 4.42 |
Filip1 |
filamin A interacting protein 1 |
728 |
0.66 |
chr4_32486662_32487238 | 4.20 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
14555 |
0.23 |
chr5_75975825_75977229 | 4.13 |
Kdr |
kinase insert domain protein receptor |
1931 |
0.31 |
chr12_52854803_52855496 | 4.10 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
59313 |
0.14 |
chr2_17458500_17459039 | 3.98 |
Nebl |
nebulette |
1852 |
0.47 |
chr6_146500226_146500471 | 3.92 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
1530 |
0.4 |
chr10_33083500_33083959 | 3.80 |
Trdn |
triadin |
168 |
0.97 |
chr10_33255178_33255436 | 3.78 |
D830005E20Rik |
RIKEN cDNA D830005E20 gene |
1050 |
0.52 |
chr15_40656769_40657228 | 3.71 |
Zfpm2 |
zinc finger protein, multitype 2 |
1647 |
0.51 |
chr2_105132016_105133665 | 3.69 |
Wt1 |
Wilms tumor 1 homolog |
1957 |
0.31 |
chr5_147723576_147724353 | 3.64 |
Flt1 |
FMS-like tyrosine kinase 1 |
2024 |
0.35 |
chr5_116419755_116420272 | 3.58 |
Hspb8 |
heat shock protein 8 |
2851 |
0.18 |
chr5_5261065_5262223 | 3.56 |
Cdk14 |
cyclin-dependent kinase 14 |
3665 |
0.25 |
chr11_65266805_65267363 | 3.55 |
Myocd |
myocardin |
2770 |
0.29 |
chr3_138278447_138278729 | 3.54 |
Adh1 |
alcohol dehydrogenase 1 (class I) |
937 |
0.44 |
chr1_187999444_187999905 | 3.52 |
Esrrg |
estrogen-related receptor gamma |
1806 |
0.42 |
chr1_51288641_51290950 | 3.49 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr10_30840531_30840931 | 3.48 |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
1284 |
0.43 |
chr5_75975434_75975824 | 3.47 |
Kdr |
kinase insert domain protein receptor |
2829 |
0.25 |
chr14_61257948_61258209 | 3.41 |
Sgcg |
sarcoglycan, gamma (dystrophin-associated glycoprotein) |
346 |
0.85 |
chr17_81737002_81738450 | 3.40 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr5_13280340_13280537 | 3.37 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
116346 |
0.06 |
chrX_168797327_168797777 | 3.35 |
Arhgap6 |
Rho GTPase activating protein 6 |
2453 |
0.35 |
chr3_145991774_145992302 | 3.35 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
1633 |
0.36 |
chr7_65366831_65368151 | 3.31 |
Gm44794 |
predicted gene 44794 |
709 |
0.67 |
chr19_53794096_53794765 | 3.27 |
Rbm20 |
RNA binding motif protein 20 |
1122 |
0.48 |
chr10_30838746_30839745 | 3.26 |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
2770 |
0.24 |
chr1_135836765_135837624 | 3.21 |
Tnnt2 |
troponin T2, cardiac |
781 |
0.54 |
chr12_117657998_117660727 | 3.19 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr1_112456627_112457016 | 3.19 |
Gm22331 |
predicted gene, 22331 |
11090 |
0.28 |
chr11_43834010_43835381 | 3.15 |
Adra1b |
adrenergic receptor, alpha 1b |
1637 |
0.47 |
chr19_36117589_36118325 | 3.11 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
1953 |
0.34 |
chr12_73846939_73847247 | 3.10 |
Gm15283 |
predicted gene 15283 |
22519 |
0.15 |
chr16_4520955_4521652 | 3.06 |
Srl |
sarcalumenin |
1760 |
0.3 |
chr17_71019478_71020561 | 2.95 |
Myom1 |
myomesin 1 |
428 |
0.76 |
chr14_63268302_63270010 | 2.93 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr9_77344708_77344864 | 2.92 |
Mlip |
muscular LMNA-interacting protein |
3007 |
0.22 |
chr8_91990955_91992233 | 2.89 |
Gm36670 |
predicted gene, 36670 |
275 |
0.89 |
chr2_79087179_79088090 | 2.86 |
Gm14469 |
predicted gene 14469 |
48900 |
0.14 |
chr8_72320830_72321486 | 2.86 |
Klf2 |
Kruppel-like factor 2 (lung) |
2125 |
0.21 |
chr17_71021282_71021597 | 2.85 |
Myom1 |
myomesin 1 |
1848 |
0.24 |
chr7_109191327_109192334 | 2.79 |
Lmo1 |
LIM domain only 1 |
16623 |
0.17 |
chr2_138277835_138280637 | 2.78 |
Btbd3 |
BTB (POZ) domain containing 3 |
743 |
0.81 |
chr6_17170071_17171190 | 2.77 |
Gm4876 |
predicted gene 4876 |
835 |
0.65 |
chr19_25343674_25344266 | 2.75 |
Gm34432 |
predicted gene, 34432 |
3233 |
0.31 |
chr3_144759210_144759685 | 2.75 |
Clca3a1 |
chloride channel accessory 3A1 |
1394 |
0.3 |
chr2_92140355_92141595 | 2.74 |
Phf21a |
PHD finger protein 21A |
43131 |
0.11 |
chr9_101198368_101199080 | 2.73 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
127 |
0.94 |
chr8_13253441_13254226 | 2.72 |
Adprhl1 |
ADP-ribosylhydrolase like 1 |
238 |
0.86 |
chr13_115100230_115100381 | 2.72 |
Gm49395 |
predicted gene, 49395 |
1319 |
0.28 |
chr8_13253140_13253419 | 2.71 |
Adprhl1 |
ADP-ribosylhydrolase like 1 |
792 |
0.46 |
chr3_152264546_152264733 | 2.71 |
Nexn |
nexilin |
1128 |
0.39 |
chr3_119498694_119499278 | 2.70 |
Gm23432 |
predicted gene, 23432 |
139888 |
0.05 |
chr19_24859802_24860526 | 2.70 |
Pgm5 |
phosphoglucomutase 5 |
1488 |
0.33 |
chr16_95456632_95459094 | 2.69 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr17_72921491_72924008 | 2.69 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr9_86438288_86439112 | 2.69 |
Ube2cbp |
ubiquitin-conjugating enzyme E2C binding protein |
26250 |
0.17 |
chrX_56736796_56737079 | 2.69 |
Fhl1 |
four and a half LIM domains 1 |
4808 |
0.18 |
chr4_94740256_94740601 | 2.68 |
Tek |
TEK receptor tyrosine kinase |
910 |
0.62 |
chr5_138609015_138609166 | 2.67 |
Gm15497 |
predicted gene 15497 |
1649 |
0.2 |
chr6_97929540_97930859 | 2.64 |
Mitf |
melanogenesis associated transcription factor |
400 |
0.89 |
chr13_81351343_81352153 | 2.64 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
122 |
0.98 |
chr2_76979769_76980006 | 2.61 |
Ttn |
titin |
295 |
0.93 |
chr5_139694738_139695088 | 2.60 |
Gm42424 |
predicted gene 42424 |
6734 |
0.17 |
chr18_10786870_10787338 | 2.59 |
Mir133a-1hg |
Mir133a-1, Mir1b and Mir1a-2 host gene |
1221 |
0.25 |
chr9_79977295_79978179 | 2.58 |
Filip1 |
filamin A interacting protein 1 |
67 |
0.97 |
chr8_35377349_35377500 | 2.57 |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
764 |
0.47 |
chr12_84589686_84590923 | 2.56 |
Abcd4 |
ATP-binding cassette, sub-family D (ALD), member 4 |
13748 |
0.15 |
chr10_120900011_120900716 | 2.55 |
Gm4473 |
predicted gene 4473 |
1206 |
0.3 |
chr5_57723598_57724600 | 2.55 |
Gm42635 |
predicted gene 42635 |
294 |
0.83 |
chr13_49545764_49546368 | 2.54 |
Aspn |
asporin |
1579 |
0.33 |
chr2_69584417_69584936 | 2.53 |
Lrp2 |
low density lipoprotein receptor-related protein 2 |
1353 |
0.48 |
chr6_112273463_112275203 | 2.53 |
Lmcd1 |
LIM and cysteine-rich domains 1 |
575 |
0.71 |
chr18_60377377_60377703 | 2.51 |
Iigp1 |
interferon inducible GTPase 1 |
1493 |
0.33 |
chr1_153330166_153330548 | 2.50 |
Lamc1 |
laminin, gamma 1 |
2429 |
0.26 |
chr1_13366348_13366754 | 2.49 |
Ncoa2 |
nuclear receptor coactivator 2 |
5878 |
0.13 |
chr10_24597252_24598120 | 2.49 |
Gm15270 |
predicted gene 15270 |
578 |
0.69 |
chr17_48432307_48432603 | 2.49 |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 |
163 |
0.92 |
chr4_44083540_44083707 | 2.49 |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
300 |
0.84 |
chr3_138000878_138001680 | 2.49 |
Gm19708 |
predicted gene, 19708 |
340 |
0.84 |
chr3_19646421_19646748 | 2.48 |
Trim55 |
tripartite motif-containing 55 |
2076 |
0.26 |
chr10_45338438_45338763 | 2.48 |
Bves |
blood vessel epicardial substance |
2828 |
0.24 |
chr3_69007997_69008720 | 2.48 |
Mir15b |
microRNA 15b |
1414 |
0.23 |
chr15_40354922_40355110 | 2.48 |
Gm41311 |
predicted gene, 41311 |
11756 |
0.28 |
chr5_66149366_66149538 | 2.45 |
Rbm47 |
RNA binding motif protein 47 |
1504 |
0.23 |
chr4_11705100_11705674 | 2.45 |
Gem |
GTP binding protein (gene overexpressed in skeletal muscle) |
420 |
0.85 |
chr14_63249784_63250324 | 2.45 |
Gata4 |
GATA binding protein 4 |
4783 |
0.2 |
chr3_68467947_68469189 | 2.44 |
Schip1 |
schwannomin interacting protein 1 |
385 |
0.89 |
chr2_80037645_80038971 | 2.44 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
721 |
0.79 |
chr3_152264342_152264493 | 2.44 |
Nexn |
nexilin |
911 |
0.47 |
chr9_24772390_24773199 | 2.44 |
Tbx20 |
T-box 20 |
1490 |
0.39 |
chr8_81856300_81856587 | 2.42 |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
75 |
0.98 |
chr15_58323594_58324160 | 2.42 |
Klhl38 |
kelch-like 38 |
292 |
0.91 |
chr14_46144218_46144892 | 2.41 |
Ubb-ps |
ubiquitin B, pseudogene |
60427 |
0.11 |
chr9_79975154_79975866 | 2.40 |
Filip1 |
filamin A interacting protein 1 |
2149 |
0.3 |
chr14_72984029_72984180 | 2.40 |
Gm9198 |
predicted gene 9198 |
4200 |
0.26 |
chr9_71590180_71590500 | 2.39 |
Myzap |
myocardial zonula adherens protein |
1925 |
0.34 |
chr5_116420481_116421179 | 2.39 |
Hspb8 |
heat shock protein 8 |
2034 |
0.22 |
chr6_119192736_119192887 | 2.37 |
Dcp1b |
decapping mRNA 1B |
455 |
0.83 |
chr3_123235460_123236700 | 2.36 |
Synpo2 |
synaptopodin 2 |
16 |
0.97 |
chr16_96202794_96202945 | 2.36 |
Sh3bgr |
SH3-binding domain glutamic acid-rich protein |
2140 |
0.24 |
chr15_94249513_94250124 | 2.35 |
Adamts20 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 20 |
154440 |
0.04 |
chr13_83526460_83526672 | 2.35 |
Mef2c |
myocyte enhancer factor 2C |
1646 |
0.51 |
chr16_64366991_64367493 | 2.35 |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
111906 |
0.07 |
chr6_15411532_15411807 | 2.34 |
Gm25470 |
predicted gene, 25470 |
6688 |
0.28 |
chr9_105520039_105521535 | 2.34 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr10_22815720_22817074 | 2.34 |
Gm10824 |
predicted gene 10824 |
648 |
0.66 |
chr6_4506970_4507670 | 2.33 |
Gm43921 |
predicted gene, 43921 |
1233 |
0.34 |
chr8_45887181_45888227 | 2.33 |
Pdlim3 |
PDZ and LIM domain 3 |
2184 |
0.22 |
chr6_52202371_52204739 | 2.33 |
Hoxa5 |
homeobox A5 |
1032 |
0.2 |
chr17_11664263_11665109 | 2.31 |
Gm10513 |
predicted gene 10513 |
67659 |
0.13 |
chr8_45884705_45886134 | 2.31 |
Pdlim3 |
PDZ and LIM domain 3 |
42 |
0.97 |
chr15_59876437_59876598 | 2.31 |
Gm7708 |
predicted gene 7708 |
53773 |
0.13 |
chr3_134201314_134201669 | 2.30 |
Gm30648 |
predicted gene, 30648 |
1405 |
0.33 |
chr4_99650241_99651897 | 2.27 |
Gm12688 |
predicted gene 12688 |
3914 |
0.16 |
chr13_102957440_102958679 | 2.27 |
Mast4 |
microtubule associated serine/threonine kinase family member 4 |
287 |
0.95 |
chr8_92361507_92362918 | 2.27 |
Irx5 |
Iroquois homeobox 5 |
4463 |
0.2 |
chr2_69670826_69672050 | 2.26 |
Klhl41 |
kelch-like 41 |
1318 |
0.37 |
chr3_79180505_79180656 | 2.25 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
760 |
0.66 |
chr6_4005760_4006960 | 2.24 |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
2456 |
0.24 |
chr17_40878873_40879024 | 2.24 |
9130008F23Rik |
RIKEN cDNA 9130008F23 gene |
1610 |
0.29 |
chr1_118481967_118482873 | 2.23 |
Clasp1 |
CLIP associating protein 1 |
381 |
0.8 |
chr7_112956295_112957421 | 2.22 |
Rassf10 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 10 |
2896 |
0.26 |
chr13_109229388_109230388 | 2.22 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
30766 |
0.25 |
chr6_39055880_39056082 | 2.21 |
1700025N23Rik |
RIKEN cDNA 1700025N23 gene |
11617 |
0.15 |
chr10_69786998_69788126 | 2.21 |
Ank3 |
ankyrin 3, epithelial |
106 |
0.98 |
chr14_101841178_101841822 | 2.20 |
Lmo7 |
LIM domain only 7 |
681 |
0.79 |
chr1_89991921_89993000 | 2.20 |
Asb18 |
ankyrin repeat and SOCS box-containing 18 |
3992 |
0.25 |
chr6_91980058_91980209 | 2.20 |
Fgd5 |
FYVE, RhoGEF and PH domain containing 5 |
1255 |
0.39 |
chr3_20153383_20154068 | 2.19 |
Gyg |
glycogenin |
1344 |
0.46 |
chr8_61901693_61901844 | 2.19 |
Palld |
palladin, cytoskeletal associated protein |
901 |
0.56 |
chr15_66559076_66559686 | 2.17 |
Tmem71 |
transmembrane protein 71 |
1722 |
0.39 |
chr3_42111234_42111590 | 2.15 |
Gm37846 |
predicted gene, 37846 |
52453 |
0.16 |
chr2_14825138_14825659 | 2.15 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
1306 |
0.4 |
chr18_4636274_4636995 | 2.15 |
Jcad |
junctional cadherin 5 associated |
1756 |
0.43 |
chr2_76980555_76980961 | 2.14 |
Ttn |
titin |
576 |
0.81 |
chr12_52855824_52856043 | 2.14 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
60097 |
0.14 |
chr2_26585065_26586013 | 2.13 |
Egfl7 |
EGF-like domain 7 |
1091 |
0.24 |
chr1_46970388_46970697 | 2.13 |
Gm28527 |
predicted gene 28527 |
73663 |
0.09 |
chr1_40874117_40874621 | 2.13 |
Gm5973 |
predicted gene 5973 |
10137 |
0.24 |
chr4_148656816_148657277 | 2.13 |
Gm572 |
predicted gene 572 |
13729 |
0.13 |
chr1_188006897_188007904 | 2.13 |
9330162B11Rik |
RIKEN cDNA 9330162B11 gene |
1590 |
0.45 |
chr8_110321934_110322150 | 2.12 |
Gm26832 |
predicted gene, 26832 |
54580 |
0.11 |
chr19_29470979_29471199 | 2.11 |
Pdcd1lg2 |
programmed cell death 1 ligand 2 |
49030 |
0.1 |
chr12_117159327_117161103 | 2.11 |
Gm10421 |
predicted gene 10421 |
8564 |
0.3 |
chr8_61899020_61899541 | 2.10 |
Palld |
palladin, cytoskeletal associated protein |
3389 |
0.22 |
chr19_28037121_28037467 | 2.09 |
Gm5517 |
predicted gene 5517 |
3830 |
0.23 |
chr4_8963181_8963460 | 2.08 |
Rps18-ps2 |
ribosomal protein S18, pseudogene 2 |
22061 |
0.26 |
chr11_19012477_19012923 | 2.08 |
Meis1 |
Meis homeobox 1 |
698 |
0.49 |
chr16_23931231_23931762 | 2.08 |
Rtp2 |
receptor transporter protein 2 |
702 |
0.67 |
chr14_27237814_27239092 | 2.07 |
Gm49616 |
predicted gene, 49616 |
391 |
0.49 |
chr4_30315998_30316149 | 2.07 |
Gm11924 |
predicted gene 11924 |
116039 |
0.07 |
chr1_135840170_135841177 | 2.06 |
Tnnt2 |
troponin T2, cardiac |
26 |
0.97 |
chr5_112894973_112895548 | 2.05 |
Myo18b |
myosin XVIIIb |
1102 |
0.54 |
chr3_129220683_129222367 | 2.05 |
Gm43697 |
predicted gene 43697 |
4003 |
0.19 |
chr2_63982565_63982778 | 2.04 |
Fign |
fidgetin |
115317 |
0.07 |
chr13_46421073_46421328 | 2.04 |
Rbm24 |
RNA binding motif protein 24 |
622 |
0.78 |
chr10_33083089_33083332 | 2.04 |
Trdn |
triadin |
273 |
0.94 |
chr17_76861111_76861262 | 2.04 |
Gm18366 |
predicted gene, 18366 |
39696 |
0.21 |
chr10_30845489_30845963 | 2.03 |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
2925 |
0.24 |
chr4_105100875_105101089 | 2.03 |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
8908 |
0.27 |
chr18_61783794_61784202 | 2.03 |
Afap1l1 |
actin filament associated protein 1-like 1 |
2613 |
0.25 |
chr1_140182332_140182724 | 2.01 |
Cfh |
complement component factor h |
752 |
0.73 |
chr11_26806712_26807274 | 2.01 |
Gm12070 |
predicted gene 12070 |
20360 |
0.19 |
chr12_31712818_31713098 | 2.01 |
Gpr22 |
G protein-coupled receptor 22 |
968 |
0.51 |
chr5_150262108_150262988 | 2.00 |
Fry |
FRY microtubule binding protein |
2781 |
0.26 |
chr1_153330663_153330955 | 2.00 |
Lamc1 |
laminin, gamma 1 |
1977 |
0.3 |
chr2_17459795_17460084 | 2.00 |
Nebl |
nebulette |
682 |
0.8 |
chrX_114477896_114478376 | 2.00 |
Klhl4 |
kelch-like 4 |
3532 |
0.28 |
chr17_44136324_44136532 | 1.99 |
Clic5 |
chloride intracellular channel 5 |
1660 |
0.43 |
chr19_30623427_30623717 | 1.99 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
1919 |
0.42 |
chr13_71961770_71962476 | 1.98 |
Irx1 |
Iroquois homeobox 1 |
1407 |
0.5 |
chr1_42229552_42230263 | 1.98 |
Gm9915 |
predicted gene 9915 |
180 |
0.95 |
chr9_67261068_67261449 | 1.98 |
Tln2 |
talin 2 |
835 |
0.67 |
chr4_118487482_118487969 | 1.98 |
Tie1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
2030 |
0.19 |
chr10_37988715_37989307 | 1.97 |
Gm24710 |
predicted gene, 24710 |
57331 |
0.15 |
chr6_52199825_52201748 | 1.96 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
338 |
0.63 |
chr9_95256675_95257394 | 1.96 |
Slc9a9 |
solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
135348 |
0.04 |
chr1_187999916_188000681 | 1.96 |
Esrrg |
estrogen-related receptor gamma |
2430 |
0.35 |
chr10_3368375_3368998 | 1.94 |
Ppp1r14c |
protein phosphatase 1, regulatory inhibitor subunit 14C |
2142 |
0.36 |
chr8_11311242_11311393 | 1.93 |
Col4a1 |
collagen, type IV, alpha 1 |
1372 |
0.31 |
chr12_117200442_117200898 | 1.93 |
Gm10421 |
predicted gene 10421 |
49019 |
0.16 |
chr8_40331087_40331414 | 1.92 |
Fgf20 |
fibroblast growth factor 20 |
22919 |
0.16 |
chr8_57315271_57316273 | 1.92 |
Hand2os1 |
Hand2, opposite strand 1 |
62 |
0.96 |
chr13_44228598_44229389 | 1.92 |
Gm47781 |
predicted gene, 47781 |
3405 |
0.22 |
chr13_72625092_72626461 | 1.92 |
Gm20554 |
predicted gene, 20554 |
2788 |
0.27 |
chr11_30264207_30264686 | 1.92 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
2768 |
0.28 |
chr2_58509453_58510324 | 1.91 |
Acvr1 |
activin A receptor, type 1 |
6384 |
0.23 |
chr6_138708519_138709263 | 1.91 |
Igbp1b |
immunoglobulin (CD79A) binding protein 1b |
50347 |
0.16 |
chr10_102513522_102514467 | 1.90 |
Rassf9 |
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
1738 |
0.36 |
chr5_146986134_146986665 | 1.90 |
Mtif3 |
mitochondrial translational initiation factor 3 |
22599 |
0.14 |
chr6_29917874_29918025 | 1.90 |
Strip2 |
striatin interacting protein 2 |
936 |
0.43 |
chr3_133338998_133339767 | 1.90 |
Ppa2 |
pyrophosphatase (inorganic) 2 |
273 |
0.93 |
chrX_85775362_85775513 | 1.90 |
Gk |
glycerol kinase |
1187 |
0.39 |
chr2_152436557_152436921 | 1.89 |
6820408C15Rik |
RIKEN cDNA 6820408C15 gene |
9077 |
0.08 |
chr3_9947586_9947797 | 1.89 |
Gm17877 |
predicted gene, 17877 |
24310 |
0.16 |
chr6_141250969_141251472 | 1.89 |
Gm28523 |
predicted gene 28523 |
1211 |
0.38 |
chr19_34251985_34252204 | 1.89 |
Acta2 |
actin, alpha 2, smooth muscle, aorta |
2136 |
0.26 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.2 | GO:0048769 | sarcomerogenesis(GO:0048769) |
2.5 | 12.4 | GO:0003175 | tricuspid valve development(GO:0003175) |
2.1 | 4.3 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
1.9 | 13.2 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
1.3 | 3.8 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.2 | 3.6 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.2 | 4.7 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.2 | 3.5 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.2 | 3.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.1 | 3.3 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.1 | 3.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.1 | 3.2 | GO:0007525 | somatic muscle development(GO:0007525) |
1.1 | 5.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.0 | 4.0 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
1.0 | 2.9 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.0 | 2.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.9 | 3.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.9 | 1.8 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.8 | 2.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 4.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 0.8 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.8 | 3.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 4.5 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.7 | 0.7 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.7 | 2.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.7 | 2.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.7 | 1.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.7 | 3.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.7 | 2.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.7 | 2.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.6 | 2.5 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.6 | 2.4 | GO:0007494 | midgut development(GO:0007494) |
0.6 | 2.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.6 | 1.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.6 | 5.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.6 | 1.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.6 | 1.7 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.6 | 2.3 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.6 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 0.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.5 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 1.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 2.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 1.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.5 | 4.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.5 | 2.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 1.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.5 | 2.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 2.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.5 | 1.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 3.0 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 1.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 1.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 2.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.4 | 1.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 0.9 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 0.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 | 3.0 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 1.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.4 | 0.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.4 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 1.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.4 | 2.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 1.2 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.4 | 1.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 1.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.4 | 0.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.4 | 1.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 1.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 1.2 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 1.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.4 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 2.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 1.9 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
0.4 | 1.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.4 | 1.5 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.4 | 1.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 1.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.4 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.4 | 0.7 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 1.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.4 | 0.4 | GO:1904672 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.4 | 1.4 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 0.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.4 | 0.4 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.3 | 3.5 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 2.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 2.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.3 | 3.7 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.3 | 3.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.3 | 4.7 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.3 | 0.3 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 1.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 1.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 1.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.3 | 0.7 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 1.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 1.0 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 1.3 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 0.6 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.3 | 2.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 0.9 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 0.6 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.3 | 3.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 0.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.3 | 0.9 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.3 | 1.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.3 | 2.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.9 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.3 | 0.9 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.3 | 0.6 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 1.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.3 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
0.3 | 0.3 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.3 | 1.1 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.3 | 2.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 0.8 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 3.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 2.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 0.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 0.8 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.3 | 1.6 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.3 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.3 | 0.5 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 1.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 3.2 | GO:0001553 | luteinization(GO:0001553) |
0.3 | 0.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 1.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.3 | 1.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 0.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 7.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 1.0 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 0.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.3 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.3 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.7 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 2.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.2 | 0.7 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 1.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 0.5 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 1.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 2.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 1.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 1.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 2.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.2 | 0.7 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.2 | 2.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.4 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.2 | 0.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.2 | 0.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.2 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.2 | GO:0003160 | endocardium morphogenesis(GO:0003160) |
0.2 | 1.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.4 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.2 | 3.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.2 | 0.4 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.2 | 0.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.2 | 0.4 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 1.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.2 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 1.0 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.2 | 0.8 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 0.6 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 1.2 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.4 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.2 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 1.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 0.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 1.7 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 0.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.2 | 3.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 3.1 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.9 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.2 | 1.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 4.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 1.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 1.5 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.2 | 1.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.5 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 2.0 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 0.7 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.2 | 1.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.3 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.2 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 0.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.2 | 0.7 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.2 | 0.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.2 | 0.2 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 0.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 4.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
0.2 | 0.6 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.6 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.2 | 0.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.2 | 0.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 1.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.6 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.2 | 0.2 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.2 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.5 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.2 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 0.2 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 0.9 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.6 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.6 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.1 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 0.4 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 1.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
0.1 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.3 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.1 | 0.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.8 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.7 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.4 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 0.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.1 | 2.4 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 1.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.4 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.8 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.1 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.1 | 0.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.1 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.1 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.1 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.4 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 1.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.1 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.2 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.2 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.1 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.1 | 0.3 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.1 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.1 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 0.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 1.2 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.4 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.1 | 0.2 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.5 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.1 | 0.2 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.1 | 0.6 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.1 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.6 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.6 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.7 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:1902337 | regulation of apoptotic process involved in morphogenesis(GO:1902337) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.2 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) |
0.1 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.2 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.1 | 0.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.1 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.1 | 0.2 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 1.0 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 0.1 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.1 | 0.1 | GO:0048793 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) pronephros development(GO:0048793) |
0.1 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.5 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.1 | 0.8 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.1 | 2.2 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.2 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.4 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.2 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.1 | 0.2 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.1 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.1 | 0.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.1 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.1 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.5 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.3 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 1.1 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.1 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.1 | 0.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
0.1 | 0.3 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.7 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.2 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.1 | 0.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.2 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.3 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.1 | 0.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.1 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.1 | 1.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.2 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.1 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 1.5 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.1 | 0.4 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.1 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 1.5 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.6 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 1.5 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.4 | GO:1904385 | angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.3 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 1.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 2.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.6 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.6 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.1 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.2 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.8 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.3 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.8 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.1 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.1 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.5 | GO:0010737 | protein kinase A signaling(GO:0010737) |
0.1 | 0.2 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 3.9 | GO:0006936 | muscle contraction(GO:0006936) |
0.1 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.6 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.1 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.3 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.2 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.7 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.0 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.0 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.9 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.6 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.0 | 0.0 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.2 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.0 | 0.0 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.0 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.1 | GO:0009164 | nucleoside catabolic process(GO:0009164) |
0.0 | 0.3 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.0 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.4 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.1 | GO:0046959 | habituation(GO:0046959) |
0.0 | 0.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.2 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.2 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.6 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 1.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.3 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.0 | 1.6 | GO:0055001 | muscle cell development(GO:0055001) |
0.0 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 1.2 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 1.1 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.0 | 0.1 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.3 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.4 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.0 | GO:0051284 | positive regulation of sequestering of calcium ion(GO:0051284) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.2 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.0 | 0.2 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.4 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.1 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.0 | 0.1 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.1 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.0 | 0.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.0 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.0 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.0 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.0 | 0.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.1 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.2 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 1.9 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.4 | GO:0045446 | endothelial cell differentiation(GO:0045446) |
0.0 | 0.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.0 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.1 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.0 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.0 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 1.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 0.0 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.0 | 0.1 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 1.8 | GO:0007015 | actin filament organization(GO:0007015) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.0 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.0 | GO:0071869 | response to catecholamine(GO:0071869) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0007135 | meiosis II(GO:0007135) |
0.0 | 0.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.0 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.0 | 0.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.0 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.0 | 0.0 | GO:0051608 | histamine transport(GO:0051608) |
0.0 | 0.0 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.3 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.0 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.2 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.2 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.4 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.0 | GO:0045938 | positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.0 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.0 | 0.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.0 | 0.0 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.0 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.0 | 0.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 0.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.0 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.0 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.3 | 3.9 | GO:0097443 | sorting endosome(GO:0097443) |
1.0 | 9.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.0 | 3.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
1.0 | 2.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.8 | 3.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 3.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 4.7 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 3.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 2.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.5 | 4.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 2.0 | GO:0030478 | actin cap(GO:0030478) |
0.5 | 1.0 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 6.8 | GO:0031430 | M band(GO:0031430) |
0.5 | 1.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 2.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 6.7 | GO:0043034 | costamere(GO:0043034) |
0.4 | 2.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 29.8 | GO:0030018 | Z disc(GO:0030018) |
0.4 | 4.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 1.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 4.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.3 | 4.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.8 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 2.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 1.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 1.0 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 2.7 | GO:0031674 | I band(GO:0031674) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.9 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 2.0 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.2 | 9.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 3.8 | GO:0014704 | intercalated disc(GO:0014704) |
0.2 | 2.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 1.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.5 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 0.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 0.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.7 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 2.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 4.8 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 1.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 2.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 3.3 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.7 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 2.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.3 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.2 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 2.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 3.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.1 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.9 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 2.2 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 6.8 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.7 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 4.8 | GO:0044420 | extracellular matrix component(GO:0044420) |
0.1 | 0.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.5 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.3 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 1.0 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 5.7 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.9 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.0 | 0.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.0 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 8.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 3.0 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.0 | 0.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 2.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.4 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.0 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 1.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 9.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 4.0 | GO:0030172 | troponin C binding(GO:0030172) |
1.2 | 3.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.2 | 3.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.1 | 5.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.0 | 2.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 5.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.9 | 2.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.8 | 4.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 2.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 2.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.8 | 5.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.8 | 2.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.7 | 0.7 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.7 | 2.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 2.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.7 | 2.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.7 | 2.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.7 | 1.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.7 | 2.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.6 | 1.8 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.6 | 2.9 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.6 | 2.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 9.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 1.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 2.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 1.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 3.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.5 | 1.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 0.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.4 | 1.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.4 | 9.5 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.4 | 1.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.4 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.4 | 2.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.4 | 2.5 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 1.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.3 | 1.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 0.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 2.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 3.6 | GO:0001846 | opsonin binding(GO:0001846) |
0.3 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 1.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 1.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 0.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 3.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 7.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 1.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 1.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 0.3 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 0.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 1.0 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 1.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 1.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.0 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 4.1 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.7 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.9 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.4 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 1.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.7 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.9 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.6 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 1.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 0.8 | GO:0010435 | succinate-CoA ligase activity(GO:0004774) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.7 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 2.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 0.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 3.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 10.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 0.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.2 | 0.6 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.2 | 0.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 2.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.5 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 2.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 14.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.1 | 0.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 1.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.3 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.1 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.0 | GO:0034944 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 2.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 10.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 3.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 1.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 7.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 1.1 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.7 | GO:0018653 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 2.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 19.0 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.6 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 1.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 5.5 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.5 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 9.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 1.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.6 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.3 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.3 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.1 | 0.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 0.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 5.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.9 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.2 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.2 | GO:0002054 | nucleobase binding(GO:0002054) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.9 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 2.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.9 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 1.5 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0036403 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.5 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.2 | GO:0035671 | enone reductase activity(GO:0035671) |
0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.3 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0034549 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.0 | 0.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 1.6 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 1.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.5 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 1.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.2 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 3.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 1.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.2 | GO:0034790 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.6 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 2.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.0 | 0.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.0 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.0 | 0.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.1 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.3 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.5 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.0 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.1 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 3.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 2.1 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 7.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 3.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 8.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 5.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 8.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 8.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 2.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 2.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 2.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 5.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 3.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 4.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 7.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.0 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 6.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 6.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.7 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 4.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 2.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 12.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 7.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.4 | 3.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 6.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 5.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 4.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 5.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.3 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 3.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 1.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 4.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 3.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 13.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 5.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 9.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 3.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.8 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 6.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.3 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 1.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 3.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.0 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |